Back

The prognostic and incremental value of T1 mapping for predicting adverse events in hypertrophic cardiomyopathy

1 September 2024 (13:55 - 14:05)
Organised by: Logo
Congress Presentation Part of: Prognostication in left ventricular hypertrophy: role of cardiac magnetic resonance imaging T1 and T2 Mapping ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Jie Wang

West China Hospital, Sichuan University, Chengdu (China)

4 More presentations in this session

Presentation thumbnail
Incremental prognostic value of late gadolinium enhancement granularity in patients with hypertrophic cardiomyopathy
Mr J. Florence (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Revisiting risk stratification in hypertrophic cardiomyopathy after the recent guidelines - LGE remains tough to beat
Doctor R. Amador (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Left atrioventricular coupling index is an independent associate of new-onset AF and stroke in hypertrophic cardiomyopathy: a CMR study
Doctor M. De Raffele (Ferrara, IT)
Abstract Slides Video
Presentation thumbnail
CMR-derived pulmonary artery to aorta ratio as a predictor of adverse outcome in patients with cardiac transthyretin amyloidosis
Doctor C. Kronberger (Vienna, AT)
Abstract Slides Video

Access the full session

Session thumbnail
Prognostication in left ventricular hypertrophy: role of cardiac magnetic resonance imaging
Video

The Event

Event poster

ESC Congress 2024

1 September 2024 13:55 CET
You may be interested in
thumbnail
Congress Session
Prognostication in left ventricular hypertrophy: role of cardiac magnetic resonance imaging
thumbnail
Congress Session
Prognostic imaging in hypertrophic cardiomyopathy and amyloidosis
thumbnail
Congress Presentation
Enhanced risk stratification in hypertrophic cardiomyopathy through the integration of extracellular volume fraction on cardiovascular magnetic resonance

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources